Author: editorial

Aurobindo Pharma will acquire an additional 20% stake in inhalation products manufacturing joint venture Luoxin Aurovitas in China from the JV partner for $5.125 million.Besides the…

Ramky Infrastructure’s order book stands is around ₹10,000 crore and the company is also hopeful of securing an additional ₹3,000 crore projects.The ₹10,000-crore order book offers…

Image used for representational purpose only. File | Photo Credit: Reuters On a review of current liquidity and financial conditions, the Reserve Bank of India (RBI)…

Ajanta Pharma has entered into an in-licensing agreement with Biocon for Semaglutide.Under the agreement, Biocon will supply Semaglutide to Ajanta for exclusive marketing in 23 countries…

Image used for representational purpose only. File | Photo Credit: Reuters After two phases of capacity expansions involving capex of ₹250 crore, India has become the…

Image used for representational purposes only. File | Photo Credit: PTI Benchmark Stock Index (BSE) Sensex slipped by 42 points in a volatile trade on Tuesday…

Image used for representational purposes only. | Photo Credit: Getty Images/istockphoto The rupee rose 3 paise to settle at 89.65 (provisional) against the U.S. dollar on…

Murugappa Group firm Cholamandalam Investment and Finance Company (CIFCL) on Tuesday (December 23, 2025) dismissed corporate misgovernance allegations as “malicious and baseless”, asserting that they were…

In 2025, gold has soared by 70%, putting it on course for its strongest annual gain since 1979.File | Photo Credit: Reuters Gold and silver prices…

Image used for representation | Photo Credit: Reuters The rupee fell 5 paise to 89.73 against the U.S. dollar in early trade on Tuesday (December 23,…